Opioid Use Disorder

Implementation facilitation at HIV clinics led to increased provision of medications for tobacco use and alcohol use disorders, but not of medications for opioid use disorders, researchers reported in JAMA Network Open.

Nonadherence to treatment with buprenorphine is associated with an increased risk of opioid overdose as well as increased spending for health care among Medicare participants, according to a study published in JAMA Psychiatry.

LAS VEGAS —Patients with pain combined with opioid use disorder could realize benefits from cognitive behavioral therapy, Ravi Prasad, PhD, said at PAINWeek 2022.

Telehealth services used by Medicare beneficiaries who initiated opioid use disorder-related care during the COVID-19 pandemic were associated with improved retention in care and reduced odds for overdose.

In recognition of International Overdose Awareness Day, HHS announced it is awarding $79.1 million in overdose prevention grants as a part of President Joe Biden’s National Drug Control Strategy.

The widespread co-use of methamphetamine and opioids were associated with nonfatal overdoses among drug users in rural United States communities, researchers reported in JAMA Network Open.

The majority of people with opioid use disorder in the United States are not receiving life-saving medication due to multiple barriers to access, according to a study published in the International Journal of Drug Policy.

The buprenorphine supply in the United States has remained stable, while the methadone supply has consistently dropped during the COVID-19 pandemic, researchers reported in JAMA Network Open.

Following the release of opioid prescription guidance from the CDC in 2016, nonopioid pain prescriptions increased every year through 2019, researchers wrote in JAMA Network Open.

Central sensitization may be an important underlying factor that complicates the treatment of chronic pain and opioid use disorders, researchers wrote in PAIN Reports.